Peggy Pinkston | Seattle Genetics, Inc. |
Clay B. Siegall | Seattle Genetics, Inc. |
Darren S. Cline | Seattle Genetics, Inc. |
Todd E. Simpson | Seattle Genetics, Inc. |
Jonathan Drachman | Seattle Genetics, Inc. |
Eric L. Dobmeier | Seattle Genetics, Inc. |
Michael Schmidt | Leerink Partners LLC |
Geoffrey Meacham | Barclays Capital, Inc. |
Slanix Alex | RBC Capital Markets LLC |
Salveen Richter | Goldman Sachs & Co. LLC |
Adnan Shaukat Butt | Guggenheim Securities |
Boris Peaker | Cowen & Co. LLC |
Andy Tsan-Yu Hsieh | William Blair & Co. LLC |
Tazeen Ahmad | Bank of America Merrill Lynch |
Good day and welcome to the Seattle Genetics Third Quarter Financial Results Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Peggy Pinkston, Vice President, Investor Relations. Please go ahead, ma'am.
Thank you, operator, and good afternoon, everyone.